EU Sues IBM Over Border Delays; China Auto Sales Plunge 27%

This update was written automatically with AI from market data and news wire reports, and published without review by a person.

Key Takeaways

  • EU-Lisa sues IBM (IBM) and partners Atos and Leonardo over years of delays and technical glitches in the Entry/Exit System (EES) smart border rollout.
  • China’s passenger vehicle sales plummeted 27.3% year-over-year in October to 1.65 million units, as the "Golden September, Silver October" peak season failed to materialize.
  • South Korean regulators fined Baemin and Coupang (CPNG) a combined 631.9 billion won ($465 million) for unfair "most-favored-nation" pricing demands on restaurants.
  • US forces conducted strikes on Iran’s Qeshm Island, targeting air defense and navigation systems; Iranian officials claim no vital infrastructure was damaged.
  • Piper Sandler issued major price target hikes for biotech leaders, raising Moderna (MRNA) to $305 and Biogen (BIIB) to $305.

Legal and Regulatory Developments

The European Union has initiated legal action against International Business Machines (IBM) and its consortium partners, Atos and Leonardo, following repeated delays to the bloc's new biometric border system. The agency overseeing the project, EU-Lisa, filed the suit in Estonia seeking remedies for missed deadlines that pushed the system's launch from 2022 to late 2025. The Entry/Exit System (EES) has been criticized for software instability and hardware failures, including malfunctioning fingerprint scanners that caused significant airport congestion during its phased rollout.

In South Korea, the Fair Trade Commission (FTC) imposed a provisional fine of 331.1 billion won on Woowa Brothers (operator of Baemin) and 300.8 billion won on Coupang (CPNG). The watchdog alleged the delivery giants abused their 90% market dominance by forcing restaurants to offer prices and promotions identical to those on rival platforms. This "most-favored-nation" requirement reportedly stifled competition and pressured merchants to raise prices across the sector.

Global Market Trends

China's automotive sector faced a sharp downturn in October, with retail passenger vehicle sales falling 27.3% to 1.65 million units. The China Passenger Car Association (CPCA) noted that the traditional "Silver October" sales boost was blunted by the expiry of purchase-tax incentives and weak domestic demand. While New Energy Vehicle (NEV) penetration reached a record 67.8%, overall market volume is expected to finish 2026 at 18.5 million units, well below the 2025 peak of 23.74 million.

In the commodities space, BHP Group (BHP) signed a Memorandum of Understanding with GoMount regarding copper cathode trade. The agreement aligns with BHP's strategy to secure long-term offtake partners as global demand for copper rises, driven by energy transition and AI infrastructure needs. Meanwhile, the Japanese government announced a 10 billion yen ($63 million) emergency package to bolster cybersecurity, specifically targeting regional banks and critical infrastructure following a series of high-profile data breaches.

Geopolitical Tensions

The Middle East remains a focal point of volatility following an overnight US strike on Iran’s Qeshm Island. According to the semi-official Fars news agency, the strikes targeted military sites and navigation aids near the Strait of Hormuz but did not disrupt essential civilian services. The action comes as Israeli and American military officials reportedly signal support for further operations to reduce Iran's military capabilities, while diplomatic efforts led by Qatar continue to seek a breakthrough in nuclear and maritime security negotiations.

Analyst Upgrades and Adjustments

Piper Sandler issued aggressive updates for the biotechnology sector on Monday. The firm raised its price target for Moderna (MRNA) to $305 from $230, citing a strengthened pipeline outlook. Similarly, Biogen (BIIB) saw its target hiked to $305 from $245, supported by positive model updates for its lupus and neurology portfolios.

Other notable analyst moves include Jefferies raising the price target for IGM Financial (IGM) to C$95 from C$91, reflecting improved assets under management. Conversely, Raymond James cut its target for Karman Holdings to $75 from $100, following a reassessment of the company's near-term growth trajectory.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Scroll to Top